Robotic extended distal pancreatectomy with splenectomy for pancreatic adenocarcinoma

Ross, Samuel W.; Przetocki, Valerie; Sucandy, Iswanto; Rosemurgy, Alexander

doi:10.1016/j.hpb.2021.06.357

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our surgical technique for robotic distal pancreatectomy and splenectomy was previously described in detail. 12,13 Data were collected in a secure Microsoft Excel database (Microsoft Corp, Redmond, WA). Statistical analysis was carried out using the GraphPad Prism 8TM software (GraphPad Software Inc., San Diego, CA).…”

Section: Methodsmentioning

confidence: 99%

“…7,8 During the following years, a number of studies were published demonstrating superior results compared to laparoscopy, including increased rate of spleen preservation, reduced risk of conversion to an open operation, and shorter length of stay. [9][10][11][12][13] Obesity is a global concern and has been steadily increasing in recent years. Currently, there are limited data regarding its effect on pancreatic surgery.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Effect of Body Mass Index on Patients’ Outcomes Following Robotic Distal Pancreatectomy and Splenectomy

Jacoby,

Ross,

Sucandy

et al. 2023

JSLS

View full text Add to dashboard Cite

Background and Objectives: Obesity has increased over the past decade, yet the correlation among body mass index (BMI), surgical outcomes, and the robotic platform are not well established. This study was undertaken to measure the impact of elevated BMI on outcomes after robotic distal pancreatectomy and splenectomy. Methods: We prospectively followed patients who underwent robotic distal pancreatectomy and splenectomy. Regression analysis was utilized to identify significant relationships with BMI. For illustrative purposes, the data are presented as median (mean 6 SD). Significance was determined at p Յ 0.05.Results: A total of 122 patients underwent robotic distal pancreatectomy and splenectomy. Median age was 68 (64 6 13.3), 52% were women, and BMI was 28 (29 6 6.1) kg/m 2 . One patient was underweight (< 18.5 kg/m 2 ), 31 had normal weight (18.5-24.9 kg/m 2 ), 43 were overweight (25-29.9 kg/m 2 ), and 47 were obese (Ն 30 kg/ m 2 ). BMI was inversely correlated with age (p = 0.05) but there was no correlation with sex (p = 0.72). There were no statistically significant relationships between BMI and operative duration (p = 0.36), estimated blood loss (p = 0.42), intraoperative complications (p = 0.64), and conversion to open approach (p = 0.74). Major morbidity (p = 0.47), clinically relevant postoperative pancreatic fistula (p = 0.45), length of stay (p = 0.71), lymph nodes harvested (p = 0.79), tumor size (p = 0.26), and 30-day mortality (p = 0.31) were related to BMI.Conclusion: BMI has no significant effect on patients undergoing robotic distal pancreatectomy and splenectomy. BMI greater than 30 kg/m 2 should not defer proceeding with robotic distal pancreatectomy with splenectomy. Limited empirical evidence exists in the literature regarding patients with a BMI greater than 30 kg/m 2 , and thus any proposed operative intervention should invoke sufficient planning and preparation.

show abstract

Section: Methodsmentioning

confidence: 99%